Murine models of neurodegenerative diseases—including prion disease, tauopathies, Alzheimer’s disease, and motor neuron disease—similarly exhibit biochemical markers of UPR overactivation, including sustained levels of phosphorylated PERK and eIF2α from early disease [36,37,38,39]. This evidence concerns the gene EIF2A and early-onset autosomal dominant Alzheimer disease.